ENTERA BIO LTD (ENTX:NASDAQ)
$3.19 -0.28 (-8.0692%)
Analysed ENTERA BIO LTD (ENTX:NASDAQ) News Sources
Entera Announces Second Quarter 2026 Financial Results and Business Updates
07-08-2026
yahoo.com
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement
13-08-2026
marketbeat.com
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18-08-2026
yahoo.com
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
08-05-2026
yahoo.com
Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation
28-05-2026
yahoo.com
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
16-06-2026
yahoo.com
ENTX Stock On Track For Best Day In Over 5 Years — What’s Driving The Rally?
22-06-2026
stocktwits.com
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
27-07-2026
yahoo.com
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
31-07-2026
yahoo.com
Entera Bio shares slip as Q2 loss comes in wider than expected
10-08-2026
advfn.com
What is the current price of ENTERA BIO LTD (ENTX:NASDAQ)?
The current price of ENTERA BIO LTD (ENTX:NASDAQ) is $3.19.
ENTERA BIO LTD (ENTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENTERA BIO LTD (ENTX:NASDAQ) since the previous trading day is $-0.28.
ENTERA BIO LTD (ENTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENTERA BIO LTD (ENTX:NASDAQ) since the previous trading day is -8.0692%.
What is the most recent average sentiment score for ENTERA BIO LTD (ENTX:NASDAQ)?
The most recent average sentiment score for ENTERA BIO LTD (ENTX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for ENTERA BIO LTD (ENTX:NASDAQ)?
The most recent sentiment for ENTERA BIO LTD (ENTX:NASDAQ) is .
SEC-8K** Filing Available For ENTERA BIO LTD (ENTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.